This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Hangzhou Adcoris Biopharma Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Gang Chen: Innovator in Antibody-Drug Conjugates
Introduction
Gang Chen is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative therapies targeting cancer.
Latest Patents
Gang Chen holds a patent for an "Anti-HER2 antibody-drug conjugate and application thereof." This invention involves an anti-human epidermal growth factor receptor 2 (anti-HER2) antibody-drug conjugate or a pharmaceutically acceptable salt thereof. The application of this conjugate is aimed at preparing an antitumor pharmaceutical product. He has 1 patent to his name.
Career Highlights
Throughout his career, Gang Chen has worked with notable companies in the biopharmaceutical sector. He has been associated with Hangzhou Adcoris Biopharma Co., Ltd. and Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory. His work in these organizations has contributed to advancements in cancer treatment.
Collaborations
Gang Chen has collaborated with several professionals in his field, including Zhenwei Miao and Tong Zhu. These collaborations have further enhanced his research and development efforts.
Conclusion
Gang Chen is a key figure in the development of innovative cancer therapies, with a focus on antibody-drug conjugates. His contributions to the field are noteworthy and continue to impact the biopharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile